| Revision as of 01:24, 8 October 2003 edit35.8.131.151 (talk) <sup>®</sup>← Previous edit | Revision as of 19:48, 16 December 2003 edit undoElBenevolente (talk | contribs)1,884 edits added fda indications, deleted incorrect information that zyprexa was marketed as anti-parkonsonianNext edit → | ||
| Line 1: | Line 1: | ||
| '''Olanzapine''' ('''Zyprexa<sup>®</sup>''') is one of the ] ] ]s. |
'''Olanzapine''' ('''Zyprexa<sup>®</sup>''') is one of the ] ] ]s. Olanzapine has been ] approved for treatment of ] and ] in ]. The ] ] ''Prozac Spotlight'' argues that a ] study demonstrated that the drug was ineffective in treatment of Parkinson's disease. | ||
| ==Side Effects== | ==Side Effects== | ||
Revision as of 19:48, 16 December 2003
Olanzapine (Zyprexa) is one of the atypical antipsychotic medications. Olanzapine has been FDA approved for treatment of schizophrenia and mania in bipolar disorder. The anti-psychiatry website Prozac Spotlight argues that a 1999 study demonstrated that the drug was ineffective in treatment of Parkinson's disease.
Side Effects
Common side effects include muscle-rigidity, muscle-stiffness, muscle-twitches, restlesness, sedation, and weight-gain. Olanzapine is reported to cause tardive dyskinesia and neurological malignant syndrome.
Olanzapine is manufactured by Eli Lilly (NYSE: LLY).